Sotac Pharmaceuticals

Sotac Pharmaceuticals Tangible Book Value per Share

The Tangible Book Value per Share of Sotac Pharmaceuticals (SOTAC.NS) as of Oct 25, 2026 is 46.45 INR. In the previous year, Tangible Book Value per Share was 39.26 INR — a change of 18.31% (higher).

Tangible Book Value per Share

46.45INR

YoY

18.31%

Last updated:

Tangible Book Value per Share of Sotac Pharmaceuticals is 2025 46.45 INR. Tangible Book Value per Share of Sotac Pharmaceuticals was 2024 39.26 INR. It decreases by 18.31% higher compared to the previous year.

The Sotac Pharmaceuticals Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2020
2.77 INR
Jan 1, 2021
2.26 INR
Jan 1, 2022
5.99 INR
Jan 1, 2024
39.26 INR
Jan 1, 2025
46.45 INR
The Sotac Pharmaceuticals Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
46.45INR+18.31%
39.26INR+555.72%
5.99INR+165.43%
2.26INR-18.43%
2.77INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals Ltd develops and manufactures pharmaceutical products under loan license or contract manufacturing agreements for various marketers. The company specializes in Non Beta-Lactam tablets, capsules, syrup, and external preparations, with a therapeutic portfolio covering Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, Anti-Allergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, Anti-Pyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams and Non-IP-Lactams, Anti-Fungal, and Cephalosporin products. Its subsidiaries SOTAC Healthcare, SOTAC Research, and SOTAC Lifescience support its manufacturing and development activities. The company generates revenue by producing pharmaceutical products on a contract manufacturing basis for different marketers, who then market and sell these products under their own brands. Sotac Pharmaceuticals' manufacturing services are utilized by various marketers seeking to outsource production without maintaining their own facilities. The firm's focus on a diverse therapeutic portfolio ensures consistent demand across multiple healthcare segments. Sotac Pharmaceuticals' manufacturing capabilities are tailored to meet the specific requirements of its marketer clients, offering both Non Beta-Lactam and Beta-Lactam product lines. The company's subsidiaries provide additional support in healthcare, research, and lifescience sectors, enhancing its overall service offerings. Its product range spans from basic medications like Anti-Cold and Anti-Allergic to specialized treatments such as Anti-Fungal and Cephalosporin antibiotics. Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

Tangible Book Value per Share of Sotac Pharmaceuticals is 46.45 INR in 2025.

Tangible Book Value per Share of Sotac Pharmaceuticals changed from 39.26 INR to 46.45 INR, representing a 18.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sotac Pharmaceuticals

All Key Metrics — Sotac Pharmaceuticals